← Eichor
Study identifier: NCT07300189 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Condition: Healthy Participants  ·  Sponsor: OrsoBio, Inc

PhasePhase 1
Planned participants288
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersYes

About this study

This phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-ascending doses in healthy subjects.

This description comes directly from the study's public registry record.

Talk to the study team

Ryan Huss, MD  ·  650-382-2225  ·  Clinicaltrials_Inquires@orsobio.com

Always discuss trial participation with your own doctor first.

Locations (1)

OrsoBio Research SiteAuckland, New ZealandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07300189